Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials-Reference-Cited by-同舟云学术

Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials

Published:2014-10-07 Issue:1 Volume:15 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Leidy Nancy K,Murray Lindsey T,Monz Brigitta U,Nelsen Linda,Goldman Mitchell,Jones Paul W,Dansie Elizabeth J,Sethi Sanjay

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1186/s12931-014-0124-z/fulltext.html

Reference41 articles.

1. Calverley PM, Georgopopoulos D: Chronic obstructive pulmonary disease: symptoms and signs. Eur Respir Mon. 2006, 38: 7-23.

2. Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004, 23: 932-946. 10.1183/09031936.04.00014304.

3. Chong-Chen LU: Bronchodilator therapy for chronic obstructive pulmonary disease. Respirology. 1997, 2: 317-322. 10.1111/j.1440-1843.1997.tb00096.x.

4. Draft guidance for industry on chronic obstructive pulmonary disease: developing drugs for treatment; availability. Fed Regist. 2007, 72: 63618-

5. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of COPD. [], [ http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf ]

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease;American Journal of Respiratory and Critical Care Medicine;2023-11-15

2. Qualitative assessment of the suitability of the Dysphagia Symptom Questionnaire to monitor dysphagia in children aged 7–10 years with eosinophilic esophagitis;Journal of Patient-Reported Outcomes;2023-10-31

3. Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial;American Journal of Respiratory and Critical Care Medicine;2023-08-15

4. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials);American Journal of Respiratory and Critical Care Medicine;2023-08-15

5. The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice;Diagnostics;2023-07-27